POLYMORPH VON FLUTICASON PROPIONAT

European patent · EP3517541 · In force

Register entry

Publication number
EP3517541
Application number
EP19156409
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 6, 2013
Published
Jul 31, 2019
Granted
Jul 15, 2020
Protection ends at the latest
May 5, 2033
Next annual fee due
May 31, 2027
IPC classes
C07J 31/00 (2006.01)
C07J 71/00 (2006.01)
A61K 31/58 (2006.01)
A61P 5/44 (2006.01)
Priority
US 201261644105 P 08.05.2012
US 201261657239 P 09.06.2012
US 201261692487 P 23.08.2012
US 201313735973 07.01.2013
US 201361763770 P 12.02.2013
US 201361788519 P 15.03.2013
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 1, 2026

    Change

    Published in Swissreg on 01.06.2026

  2. Jun 1, 2025

    Change

    Published in Swissreg on 01.06.2025

  3. Jun 2, 2024

    Change

    Published in Swissreg on 02.06.2024

  4. Jun 1, 2023

    Change

    Published in Swissreg on 01.06.2023

  5. Aug 7, 2020

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 07.08.2020

  6. Jul 15, 2020

    Granted

    Published in Swissreg on 15.07.2020

Parties

Holder

Nicox Ophthalmics, Inc.

4721 Emperor Blvd. Suite 260, Durham, NC 27703, US

Agent

Isler & Pedrazzini AG

Postfach 1772, 8027 Zürich

Inventor

CAVANAGH, Thomas

Oxford, OX4 4GA, GB

LELAND, Thomas B.

Bolton, MA 01740, US

HAO, Tian

20091 Bresso (MI), IT

THEKKEDATH, Ritesh V.

Dombivli (E). M.S., IN

BARMAN, Shikha P.

Bedford, MA 01730, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.